VanEck Vectors Pharmaceutical ETF (PPH)

Add to Watchlists
Create an Alert
51.45 +0.37  +0.72% NASDAQ Dec 2, 20:00 Delayed 2m USD
View Full Chart
PPH Price Chart

PPH Key Stats

Expense Ratio 0.36%
Share Class Assets Under Management 256.70M
30-Day Average Daily Volume Upgrade
Net Asset Value 51.46
Discount or Premium to NAV -0.02%
Turnover Ratio 12.00

PPH Performance

  Total Return Cat. Total Return (NAV) % Rank in Cat. (NAV) Cat. Total Return (Price) % Rank in Cat. (Price)
1M -1.72% -- 94 -- 78
3M -12.23% -- 97 -- 97
6M -13.28% -- 98 -- 93
1Y -18.07% -- 91 -- 78
3Y 1.82% -- 97 -- 86
5Y -- -- -- -- 100
As of Dec. 2, 2016
Returns for periods of 1 year and above are annualized.

PPH Asset Allocation

Type % Net % Long % Short
Cash -0.08% 0.00 0.08%
Stock 100.0% 100.0% 0.00
Bond 0.00 0.00 0.00
Convertible 0.00 0.00 0.00
Preferred 0.00 0.00 0.00
Other 0.05% 0.05% 0.00
As of Dec. 1, 2016

PPH Region Exposure

Americas 70.57%
North America 70.57%
Latin America 0.00
Greater Europe 29.43%
United Kingdom 10.76%
Europe Developed 14.95%
Europe Emerging 0.00
Africa/Middle East 3.72%
Greater Asia 0.00
Japan 0.00
Australasia 0.00
Asia Developed 0.00
Asia Emerging 0.00
Market Classification
% Developed Markets 100.0%
% Emerging Markets 0.00
As of Dec. 1, 2016
Region breakdown data is calculated by using the long position holdings of the portfolio.

PPH Stock Sector Exposure

Basic Materials 0.00
Communication Services 0.00
Consumer Cyclical 0.00
Consumer Defensive 0.00
Energy 0.00
Financial Services 0.00
Healthcare 100.0%
Industrials 0.00
Real Estate 0.00
Technology 0.00
Utilities 0.00
As of Dec. 1, 2016

PPH Stock Market Capitalization

Giant 55.41%
Large 27.32%
Medium 15.79%
Small 1.48%
Micro 0.00
As of Dec. 1, 2016

PPH Stock Style Exposure

Large Cap Value 8.96%
Large Cap Blend 53.58%
Large Cap Growth 20.18%
Mid Cap Value 9.29%
Mid Cap Blend 3.63%
Mid Cap Growth 2.87%
Small Cap Value 0.84%
Small Cap Blend 0.64%
Small Cap Growth 0.00
As of Dec. 1, 2016
View More Holdings

PPH Top 10 Holdings

Symbol Name % Weight Price % Chg
SNY Sanofi SA ADR 5.82% 40.02 +0.76%
BMY Bristol-Myers Squibb Company 5.73% 55.96 +0.29%
MRK Merck & Co Inc 5.61% 61.13 +0.61%
JNJ Johnson & Johnson 5.40% 111.96 +0.52%
ABBV AbbVie Inc 5.29% 59.43 +0.46%
PFE Pfizer Inc 5.24% 31.63 +0.54%
GSK GlaxoSmithKline PLC ADR 4.96% 37.70 +0.72%
ZTS Zoetis Inc 4.94% 49.10 -0.12%
NVS Novartis AG ADR 4.89% 68.17 +0.62%
ABT Abbott Laboratories 4.69% 37.90 +0.80%
As of Dec. 1, 2016
Advertisement

PPH One Page Reports

PPH Basic Info

Style
Equity Style Large Cap/Blend
Broad Asset Class Sector Equity
Broad Category Equity
Category Name Health
Prospectus Objective Specialty - Health
Fund Owner Firm Name Market Vectors
Benchmark Index
MVIS US Listed Pharmaceutical 25 NR USD
100.0%

PPH Manager Info

Name Tenure
George Chao 4.87 yrs
Hao-Hung (Peter) Liao 4.87 yrs

PPH Net Fund Flows

1M 58.88M
3M 14.74M
6M 21.59M
YTD -53.10M
1Y -7.363M
3Y -14.39M
5Y -223.25M
10Y --
As of Nov. 30, 2016

PPH Risk Info

Beta 0.9228
Max Drawdown (All) 30.30%
Historical Sharpe (10Y) --
Historical Sortino (All) 1.291
30-Day Rolling Volatility 24.64%
Daily Value at Risk (VaR) 1% (All) 2.46%
Monthly Value at Risk (VaR) 1% (All) 8.94%

PPH Fundamentals

Dividend Yield TTM (12-2-16) 2.59%
SEC Yield (10-30-15) 1.82%
Weighted Average PE Ratio 23.95
Weighted Average Price to Sales Ratio 1.060
Weighted Average Price to Book Ratio 2.915
Weighted Median ROE 21.49%
Weighted Median ROA 6.38%
Forecasted Dividend Yield 2.53%
Forecasted PE Ratio 18.78
Forecasted Price to Sales Ratio 0.958
Forecasted Price to Book Ratio 2.560
Number of Holdings 28
As of Dec. 1, 2016

PPH Growth Estimates

Forecasted 5 Yr Earnings Growth 7.89%
Forecasted Book Value Growth 7.50%
Forecasted Cash Flow Growth 12.89%
Forecasted Earnings Growth 0.63%
Forecasted Revenue Growth 12.63%
As of Dec. 1, 2016

PPH Comparables

Edit

PPH Attributes

Key Dates
Inception Date 12/20/2011
Last Annual Report Date 9/30/2015
Last Prospectus Date 2/1/2016
Attributes
Exchange Traded Share Yes
Exchange Traded Note No
Enhanced Index Fund No
Index Fund Yes
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

PPH Excel Add-In Codes

  • Name: =YCI("PPH","name")
  • Broad Asset Class: =YCI("PPH", "broad_asset_class")
  • Broad Category: =YCI("PPH", "broad_category_group")
  • Prospectus Objective: =YCI("PPH", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.